Skip to content
DataLookout
Menu

MOMAGPNONA01NCT07881159

National Registry of Noonan Syndrome

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Trial sites reduced: 35 → 13 locations
    • Site details revised at 2 of 13 sites
  2. Minor Study sites: 35 to 13
    • Study title shortened, about 5 words
  3. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Establish a national disease registry
Timeframe: 5 years
Describe the clinical characteristics of a large population of individuals with Noonan syndrome and the possible genotype-phenotype correlation
Timeframe: 5 years
Provide an online platform for healthcare professionals to report demographic and clinical information on patients with Noonan syndrome
Timeframe: 5 years

Secondary (3)

Evaluate growth curves and any short- and/or long-term complications in individuals with Noonan syndrome, with or without growth hormone (GH) treatment
Draft specific recommendations for the long-term follow-up of these patients
Facilitate future clinical trials in individuals with this condition

Arms and interventions

People of any age and sex with Noonan syndrome confirmed by a genetic test

Sites

13 sites in 1 country